Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
Tricoci, Pierluigi
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. [electronic resource] - The New England journal of medicine Jan 2012 - 20-33 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa1109719 doi
Acute Coronary Syndrome--drug therapy
Aged
Angioplasty
Cardiovascular Diseases--mortality
Combined Modality Therapy
Coronary Artery Bypass
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Hemorrhage--chemically induced
Humans
Intracranial Hemorrhages--chemically induced
Kaplan-Meier Estimate
Lactones--adverse effects
Male
Middle Aged
Platelet Aggregation Inhibitors--adverse effects
Pyridines--adverse effects
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. [electronic resource] - The New England journal of medicine Jan 2012 - 20-33 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa1109719 doi
Acute Coronary Syndrome--drug therapy
Aged
Angioplasty
Cardiovascular Diseases--mortality
Combined Modality Therapy
Coronary Artery Bypass
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Hemorrhage--chemically induced
Humans
Intracranial Hemorrhages--chemically induced
Kaplan-Meier Estimate
Lactones--adverse effects
Male
Middle Aged
Platelet Aggregation Inhibitors--adverse effects
Pyridines--adverse effects